Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Repair Schwann cells are a specialized, transient cell phenotype that arises when mature Schwann cells undergo reprogramming in response to nerve injury. This phenotype is characterized by the de-differentiation and upregulation of regenerative programs, including secretion of neurotrophic and growth factors (GDNF, BDNF, NGF, NT-3, VEGF), recruitment of macrophages via cytokine signaling, activation of autophagy for myelin clearance, and formation of guiding tracks (bands of Büngner) to support axonal regrowth. These repair cells are essential for successful peripheral nerve regeneration, but their regenerative capacity diminishes in chronic denervation or aging, often due to reduced expression of key regulators such as c-Jun. The “Schwann cell-like neuronal regeneration-promoting activity” therefore reflects a multifactorial, cell-based process rather than a classical molecular target[1][2][3][4][5][7].
Enhancement of neurotrophic factor expression; Promotion of c-Jun pathway signaling; Facilitation of autophagy and myelin clearance; Support of axonal guidance and scaffold formation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Schwann cell repair phenotype.